Showing 13,301 - 13,320 results of 34,719 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( 5 point decrease ))', query time: 1.03s Refine Results
  1. 13301

    Behavior effects after LABP acute exposure. by Kassia Martins Fernandes Pereira (12219197)

    Published 2022
    “…Asterisks indicate statistical differences between groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). n = 24/group a-20 min; 28/group b-20 min; 28/group c-25 min; 50/group d-60 min.…”
  2. 13302
  3. 13303
  4. 13304
  5. 13305

    Impaired bone formation in <i>Col1a1-Krm2</i> transgenic mice. by Jochen Schulze (365258)

    Published 2013
    “…<p>(A) Toluidine blue staining of non-decalcified vertebral body sections from 6 weeks old female wildtype and <i>Col1a1-Krm2</i> transgenic littermates revealing that the normal appearance of cuboidal osteoblasts (arrows) covering trabecular bone surfaces is only observed in wildtype controls (scale bars, 50 µm). …”
  6. 13306

    Barbie audit data. by Cylie Williams (3446018)

    Published 2025
    “…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
  7. 13307

    The FEET system of barbie categorisation. by Cylie Williams (3446018)

    Published 2025
    “…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
  8. 13308

    S1 Graphical abstract - by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  9. 13309

    The top 10 hub targets. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  10. 13310

    Original images for blots and gels requirements. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  11. 13311

    The top 10 active ingredients. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  12. 13312
  13. 13313

    The flow chart. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  14. 13314

    The active ingredients in RB-HMM. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  15. 13315

    Physiologic values. by Hiroki Iwata (2434012)

    Published 2023
    “…The serum syndecan-1 concentration, a glycocalyx component, in the 4% hydrogen group (5.7 ± 4.4 pg/mL) was lower than in the control (19.5 ± 6.6 pg/mL) and 2% hydrogen (19.8 ± 5.0 pg/mL) groups (<i>P</i> < 0.001 for each), but it was not significantly different from the sham group (6.2 ± 4.0 pg/mL, <i>P</i> = 0.999). …”
  16. 13316
  17. 13317
  18. 13318
  19. 13319

    Cox analysis. by Edwin Aguirre-Milachay (15453672)

    Published 2025
    “…</p><p>Conclusions</p><p>Factors associated with survival were arterial hypertension and iROX < 3.85 with a mortality hazard of 1.5 times, age older than 60 years, and respiratory effort scale at admission WOB ≥ 4 points with more than twice the mortality hazard. …”
  20. 13320

    Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial by Kaiyun Chen (364164)

    Published 2013
    “…The follow-up ended in January 2010, and lasted for 7.7–106.4 months with a median of 47.6 months. TTR was significantly longer in the <sup>125</sup>I group (mean of 60.0 months vs. 36.7 months in the control). …”